An emerging pharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body.


Updates from The Motley Fool

Latest updates on Sucampo Pharmaceuticals from Fool.com.


Stock Performance

SCMP vs. S&P 500 | 2 Year Performance
View Interactive SCMP Charts
Sponsored by

Key Data Points

Primary metrics and data points about Sucampo Pharmaceuticals.
Current Price: $12.79
Prev Close: $12.97
Open: $12.96
Bid: $12.85
Ask: $12.88
Day's Range: $12.78 - $13.03
52wk Range: $9.59 - $22.11
Volume: 74,104
Avg Vol 300,966
Market Cap: $579.60M
P/E (ttm): 48.04
EPS (ttm): $0.27
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Sucampo Pharmaceuticals.
CAPS Rating 4 out of 5
 
120 Outperform
13 Underperform
CAPS All Stars
 
21 Outperform
3 Underperform

How do you think Sucampo Pharmaceuticals will perform against the market?



You pick for Sucampo Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Ryuji Ueno, CEO

69% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Sucampo Pharmaceuticals.

An emerging pharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers